Comparison of Simplified Acute Physiology Score (SAPS II) , Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation) APACHE II Scoring Systems for Predicting Mortality of Critically Ill Patients Admitted in a Tertiary Hospital Intensive Care Unit. (SAPS II SOFA)

August 19, 2026 updated by: Ashmita Paudel, Tribhuvan University Teaching Hospital, Institute Of Medicine.

Comparison of SAPS II, SOFA and APACHE II Scoring Systems for Predicting Mortality of Critically Ill Patients Admitted in a Tertiary Hospital Intensive Care Unit

This is a descriptive analytical prospective study to compare the performance of SOFA score, SAPSII score and APACHE II score in ICU mortality prediction.

Study Overview

Status

Completed

Conditions

Detailed Description

All the eligible patients admitted to the ICU are enrolled in the study. For each enrolled patient SAPS II, SOFA and APACHE II score will be calculated and these patient will be followed till they are in ICU stay. A comparison of predictive performance of each score will be done for mortality in the ICU.

Study Type

Observational

Enrollment (Actual)

201

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bagmati
      • Bharatpur, Bagmati, Nepal
        • Bharatpur Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Admitted to ICU

Description

Inclusion Criteria:

18 years and above Admitted to ICU with expected stay of more or equal to 24 hours

Exclusion Criteria:

  • whose consent could not be obtained
  • treatment limitation order in form of DNI/DNR, withdrawal of life support

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality
Time Frame: Through study period on average 1 year
ICU mortality
Through study period on average 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ashmita Paudel, Bharatpur Eye Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Actual)

December 30, 2025

Study Completion (Actual)

January 30, 2026

Study Registration Dates

First Submitted

August 12, 2026

First Submitted That Met QC Criteria

August 19, 2026

First Posted (Actual)

August 21, 2026

Study Record Updates

Last Update Posted (Actual)

August 21, 2026

Last Update Submitted That Met QC Criteria

August 19, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 081/82-067

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe